...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Azomethines, isoxazole, N-substituted pyrazoles and pyrimidine containing curcumin derivatives: Urease inhibition and molecular modeling studies
【24h】

Azomethines, isoxazole, N-substituted pyrazoles and pyrimidine containing curcumin derivatives: Urease inhibition and molecular modeling studies

机译:氮杂甲磺酸汀,异恶唑,N-取代的吡唑和含吡啶胺衍生物:脲酶抑制和分子建模研究

获取原文
获取原文并翻译 | 示例
           

摘要

Curcumin has shown large number of pharmacological properties against different phenotypes of various disease models. Different synthetic routes have been employed to develop its various derivatives for diverse biological functions. In this study, curcumin derived azomethine, isoxazole, pyrimidines and N-substituted pyrazoles were synthesized to investigate their urease enzyme inhibition. The structures of newly synthesized compounds were described by IR, MS, H-1 NMR and C-13 NMR spectral data. Urease enzyme inhibition was evaluated through in vitro assays in which compound 8b was found to be the most potent (IC50 = 2.44 +/- 0.07 mu M) among the tested compounds. The compounds with diazine ring system except the 4d showed better urease inhibition (IC50 = 11.43 +/- 0.21-19.63 +/- 0.28 mu M) than the standard urease inhibitor thiourea (IC50 = 22.61 +/- 0.23 mu M). Similarly enzyme kinetics data revealed that compounds 3c-3e and 8b were competitive inhibitors with Ki values of 20.0, 19.87, 20.23 and 19.11 mu M respectively while the compounds 4b, 4c and 4e were mixed type of inhibitors with Ki values 6.72,19.69 and 6.72 mu M respectively. Molecular docking studies were also performed to identify the plausible binding modes of the most active compounds. (C) 2017 Elsevier Inc. All rights reserved.
机译:针对各种疾病模型的不同表型,姜黄素显示出大量的药理学性质。采用不同的合成路线来开发其各种衍生物以获得各种生物学功能。在该研究中,合成姜黄素衍生的唑氟甲磺酸丁胺,异恶唑,嘧啶和N-取代的吡唑,以研究其脲酶酶抑制。 IR,MS,H-1 NMR和C-13 NMR光谱数据描述了新合成化合物的结构。通过体外测定评估脲酶酶抑制,其中发现化合物8B是测试化合物中最有效的(IC50 = 2.44 +/-0.07μm)。除了4D之外的二嗪环系统的化合物显示出比标准脲酶抑制剂硫脲(IC50 = 22.61 +/-0.23μm)的尿素抑制(IC50 = 11.43 +/- 0.21-19.63 +/-0.28μm)。类似地,酶动力学数据显示,化合物3C-3E和8B分别是具有20.0,19.87,20.23和19.11μm的竞争性抑制剂,同时化合物4b,4c和4e是具有ki值的混合型抑制剂,其中ki值为6.72,19.69和6.72亩m分别。还进行了分子对接研究以鉴定最活性化合物的可粘性结合模式。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号